| 1 |
Xiao P, Chen QF, Yang YL, Guo ZH, Chen H. Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc. World J Gastroenterol 2006; 12(3): 482-484 [PMID: 16489655 DOI: 10.3748/wjg.v12.i3.482] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Sheiner PA, Florman SS, Emre S, Fishbein T, Schwartz ME, Miller CM, Boros P. Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels. Mediators Inflamm 2001;10:37-41. [PMID: 11324903 DOI: 10.1080/09629350124104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 3 |
Sawayama Y, Hayashi J, Kawakami Y, Furusyo N, Ariyama I, Kishihara Y, Ueno K, Kashiwagi S. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection. Dig Dis Sci 1999;44:163-9. [PMID: 9952238 DOI: 10.1023/a:1026674705459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 4 |
Hayashi J, Kishihara Y, Yamaji K, Yoshimura E, Ohmiya M, Tani Y, Ikematsu H, Kashiwagi S. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus. Dig Dis Sci 1995;40:1837-41. [PMID: 7648988 DOI: 10.1007/BF02212710] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 5 |
Quiroga JA, Martin J, Pardo M, Carreño V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci 1994;39:2485-96. [PMID: 7956620 DOI: 10.1007/BF02087671] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 6 |
Pfeffel F, Pidlich J, Petermann D, Müller C. Soluble CD8 and soluble CD4 antigens in viral hepatitis and alcoholic cirrhosis. J Hepatol 1994;20:245-51. [PMID: 8006406 DOI: 10.1016/s0168-8278(05)80065-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 7 |
Biancone L, Boirivant M, Fais S, Ricci GL, Paganelli R, Pallone F. Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation. Clin Exp Immunol 1991;83:401-6. [PMID: 2004483 DOI: 10.1111/j.1365-2249.1991.tb05651.x] [Reference Citation Analysis]
|
| 8 |
Wagner F, Assemi C, Lersch C, Hart R, Classen M. Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice. Clin Exp Immunol 1990;82:344-9. [PMID: 2122935 DOI: 10.1111/j.1365-2249.1990.tb05450.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Casafont F, Echevarria S, Pons Romera F. Interleukin-2 activity and serum levels of soluble interleukin-2 receptors in chronic active hepatitis B. Dig Dis Sci 1990;35:1045. [PMID: 2248665 DOI: 10.1007/BF01537254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 10 |
Semenzato G, Bambara LM, Biasi D, Frigo A, Vinante F, Zuppini B, Trentin L, Feruglio C, Chilosi M, Pizzolo G. Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. J Clin Immunol 1988;8:447-52. [PMID: 3065351 DOI: 10.1007/BF00916949] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 1.5] [Reference Citation Analysis]
|
